ALICIA PAUL: Open Payments
NPI 1558147645 · DUBLIN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$566 in 31 payments from 11 companies in 2025. Trend: 2023 $63 · 2024 $372 · 2025 $566
Food & beverage: $566
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 4 | $95 |
| Axsome Therapeutics, Inc. | 4 | $71 |
| Janssen Pharmaceuticals, Inc | 4 | $69 |
| E.R. Squibb & Sons, L.L.C. | 4 | $67 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| ABBVIE INC. | 3 | $49 |
| Lundbeck LLC | 2 | $47 |
| Teva Pharmaceuticals USA, Inc. | 3 | $46 |
| Neurocrine BioSciences, Inc. | 2 | $31 |
| Indivior Inc. | 1 | $18 |
Products named: REXULTI, ARISTADA, Auvelity, INVEGA SUSTENNA, COBENFY, VRAYLAR, AUSTEDO XR, ABILIFY ASIMTUFII.
Industry payments across OH — which companies pay providers there.
